← Back to Search
Mast Cell Effector Mechanisms.
S. Lane, T. Lee
Published 1996 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Several lines of evidence support the central role of the cysteinyl leukotrienes in aspirin-sensitive asthma, although their cellular source is unknown. The two most likely cells are the mast cell and eosinophil. Compared with aspirin-tolerant patients with asthma, patients with aspirin-sensitive asthma have been found to have a greater infiltration of mast cells and eosinophils in bronchial biopsy samples, although proportions of activated eosinophils were similar. Findings that support the involvement of mast cells include elevated serum histamine and tryptase levels after aspirin challenge in sensitive subjects, in line with a decrease in lung function and increased histamine and leukotriene C4 levels in nasal secretions; release of high-molecular-weight neutrophil chemotactic factor into serum after challenge; and prevention of aspirin-induced bronchoconstriction by pretreatment with cromolyn sodium or nedocromil sodium. These agents are also effective in protecting against bronchoconstriction induced by hyperosmolar stimuli, a challenge that is not associated with increased leukotriene E4 responsiveness but that is followed by increased release of histamine and prostaglandin D2 into bronchoalveolar lavage fluid. Antihistamines are poorly effective at inhibiting aspirin-induced bronchoconstriction but have been shown to attenuate the bronchoconstrictor response to hyperosmolar challenge. The main effector mechanism in hyperosmolar-induced bronchoconstriction appears to be mast cell activation and histamine release.
This paper references
Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.
M. Samter (1968)
Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation.
N. Martelli (1977)
Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells.
P. Eggleston (1984)
The effect of astemizole on exercise-induced asthma.
M. Clee (1984)
Terfenadine in exercise induced asthma.
K. Patel (1984)
Airflow-induced bronchoconstriction: role of epithelium and eicosanoid mediators.
A. Freed (1987)
Stimulated T cell and natural killer (NK) cell lines fail to synthesize leukotriene B4.
M. Goldyne (1987)
Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients.
C. Ortolani (1987)
Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin.
N. Ferreri (1988)
The relative responsiveness to inhaled leukotriene E4, methacholine and histamine in normal and asthmatic subjects.
S. O'Hickey (1988)
The effect of azelastine on exercise-induced asthma.
H. Magnussen (1988)
A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma.
N. Belcher (1988)
Mediator release in an isolated airway segment in subjects with asthma.
T. Gravelyn (1988)
Human B and T lymphocytes convert leukotriene A4 into leukotriene B4.
B. Odlander (1988)
Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine.
J. Finnerty (1989)
Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma.
J. Arm (1989)
Selective histamine blockade in childhood asthma; the effect of terfenadine on resting bronchial tone and exercise induced bronchoconstriction.
P. Macfarlane (1989)
Etiology of nasal polyps associated with aspirin-sensitive asthma.
T. Yamashita (1989)
Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine.
J. Arm (1990)
Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.
P. Christie (1991)
The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.
P. Christie (1991)
Pneumonologia i alergologia polska
Polskie Towarzystwo Ftizjopneumonologiczne (1991)
[Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity].
M. Szmidt (1991)
Tryptase and histamine release during aspirin-induced respiratory reactions.
J. Bosso (1991)
Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.
P. Christie (1992)
Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge.
U. Juergens (1992)
Urinary leukotriene E4 in bronchial asthma.
C. Smith (1992)
Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo.
D. Maxwell (1993)
The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
E. Israel (1993)
[Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma].
R. Yoshimi (1993)
The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
B. Dahlén (1993)
Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.
P. Christie (1993)
Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
A. Fischer (1994)
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.
K. Sladek (1994)
Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects.
S. Nasser (1996)
This paper is referenced by
Suppressive Effect of Carnosol on Ovalbumin-Induced Allergic Asthma
Jung-eun Lee (2020)
Asthma: newer Tx options mean more targeted therapy.
Parth M Rali (2020)
Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma
M. Kim (2019)
Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments.
Jae-Yeong Heo (2019)
Anti-allergic effects of sesquiterpene lactones from Saussurea costus (Falc.) Lipsch. determined using in vivo and in vitro experiments.
B. Lee (2018)
Molecular imaging of pulmonary diseases
J. Dimastromatteo (2018)
Assessment of chemical-induced local irritation and inflammation in organotypic lung tissue model-Precision-cut lung slices (PCLS)
Von der Naturwissenschaftlichen (2017)
Diagnosis and Management of Asthma in Adults: A Review
J. L. McCracken (2017)
Aspirin-Exacerbated Respiratory Disease.
E. Walgama (2017)
Anti-Allergic Effect of Oroxylin A from Oroxylum indicum Using in vivo and in vitro Experiments
Ae-Yeon Lee (2016)
Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.
T. Pera (2016)
Anti-allergic effect of α-cubebenoate isolated from Schisandra chinensis using in vivo and in vitro experiments.
Kyoung-pil Lee (2015)
Passive transfer of lipopolysaccharide-derived myeloid-derived suppressor cells inhibits asthma-related airway inflammation.
H-Z Fan (2015)
Clinical research on asthma through bronchial biopsy: investigación clínica en asma mediante biopsia bronquial
N. S. Brienza (2015)
Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS).
L. Lauenstein (2014)
R. W. Gotshall (2012)
Inflammatory Diseases: Mechanisms and Natural Remedies
Rabih S Talhouk (2012)
Pathogenic Mechanisms andInVitro Diagnosis of AERD
Dirk Sch (2012)
Pathogenic Mechanisms and In Vitro Diagnosis of AERD
D. Schaefer (2012)
Chapter 3 – Diseases of the conductive airways
B. Corrin (2011)
Chapter 1 – The structure of the normal lungs
B. Corrin (2011)
Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma
D. Durrant (2010)
The development of exhaled breath condensate: a noninvasive method of measuring airway inflammation
P. Rosias (2008)
PGE2 suppresses excessive anti‐IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease
X. Wang (2007)
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
A. Nadeem (2006)
Immunopathogenesis of Asthma
S. Y. Lee (2006)
CpG-Motive im Mausmodell für allergisches Asthma – Einfluß immunstimulatorischer DNA-Sequenzen auf die Entwicklung der allergischen Sensibilisierung und bronchialen Hyperreagibilität
Julius H. Liller (2005)
Inflammatory Features of Childhood Asthma
M. Krawiec (2005)
Modulation of Immune Response in Long-Term Use of Inhaled Corticosteroid in Childhood Asthma Receiving Specific Immunotherapy
A. Harsono (2005)
Regulation of Fc Receptor Expression and Signaling on Murine Mast Cells
H. Chong (2004)
Expression and functional characterization of CFTR in mast cells
M. Kulka (2002)
Patogenesis Asthma Bronchiale
Widura Widura (2002)See more